| Health / Medical Topics |
Akt inhibitor AZD5363
A novel pyrrolopyrimidine derivative, and an orally available inhibitor of the serine/threonine protein kinase AKT (protein kinase B) with potential antineoplastic activity. AKT inhibitor AZD5363 binds to and inhibits all AKT isoforms. Inhibition of AKT prevents the phosphorylation of AKT substrates that mediate cellular processes, such as cell division, apoptosis, and glucose and fatty acid metabolism. A wide range of solid and hematological malignancies show dysregulated PI3K/AKT/mTOR signaling due to mutations in multiple signaling components. By targeting AKT, the key node in the PIK3/AKT signaling network, this agent may be used as monotherapy or combination therapy for a variety of human cancers. (NCI Thesaurus)
YOU MAY ALSO LIKE
An orally bioavailable inhibitor of the serine/threonine protein kinase AKT (protein kinase B) with potential antineoplastic activity. AKT inhibitor ARQ 092 binds…
A molecular genetic abnormality indicating the presence of mutations in the AKT family of genes. This family includes the AKT1, AKT2,…
An orally bioavailable inhibitor of the serine/threonine protein kinase AKT (protein kinase B) isoforms 1 and 2 (AKT1/2) with potential antineoplastic…
A group of enzymes involved in several processes related to cell growth and survival. Akt enzymes help to transfer signals inside…
A British Overseas Territory comprising a peninsula on the southern coast of Cyprus.
Human AKR7A2 wild-type allele is located within 1p35.1-p36.23 and is approximately 8 kb in length. This allele, which encodes aflatoxin B1 aldehyde…
